Influence of hypovolemia on the pharmacokinetics and electroencephalographic effect of γ-hydroxybutyrate in the rat

Anesthesiology

Volumn 97, Issue 5, 2002, Pages 1218-1226

  Van Sassenbroeck, Diederik K ^a   De Paepe, Peter ^b   Belpaire, Frans M ^a   Boon, Paul A ^b   Buylaert, Walter A ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; OXYBATE SODIUM; PROPOFOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; COMPARTMENT MODEL; CONTROLLED STUDY; CORNEA REFLEX; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG SENSITIVITY; ELECTROENCEPHALOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; HYPOVOLEMIA; HYSTERESIS; INFUSION; MEAN ARTERIAL PRESSURE; MICHAELIS CONSTANT; MOLECULAR MODEL; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT;

ANESTHETICS, INTRAVENOUS; ANIMALS; BLOOD PRESSURE; ELECTROENCEPHALOGRAPHY; HYPOVOLEMIA; MALE; MODELS, BIOLOGICAL; RATS; RATS, WISTAR; SODIUM OXYBATE;

EID: 0036840786     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200211000-00027     Document Type: Article

References (42)

1. Harrison GG: Death attributable to anaesthesia: A 10-year survey (1967-1976). Br J Anaesth 1978; 50:1041-6
2. Benowitz N, Forsyth RP, Melmon KL, Rowland M: Lidocaine disposition kinetics in monkey and man: II. Effects of hemorrhage and sympathomimetic drug administration. Clin Pharmacol Ther 1974; 16:99-109
3. Klokowski PM, Levy G: Kinetics of drug action in disease states: XXIII. Effect of acute hypovolemia on the pharmacodynamics of phenobarbital in rats. J Pharm Sci 1988; 77:365-6
4. Egan TD, Kuramkote S, Gong G, Zhang J, McJames SW, Bailey PL: Fentanyl pharmacokinetics in hemorrhagic shock. A porcine model. Anesthesiology 1999; 91:156-66
5. Adams P, Gelman S, Bradley E: Midazolam pharmacodynamics and pharmacokinetics during acute hypovolemia. Anesthesiology 1985; 63:140-6
6. De Paepe P, Belpaire FM, Rosseel MT, Van Hoey G, Boon PA, Buylaert WA: Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of propofol in the rat. Anesthesiology 2000; 96:1482-90
7. De Paepe P, Belpaire FM, Van Hoey G, Boon PA, Buylaert WA: Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of etomidate in the rat. J Pharmacol Exp Ther 1999; 290:1048-53
8. Boyd AJ, Sherman IA, Saibil FG: The cardiovascular effects of gammahydroxybutyrate following hemorrhage. Circ Shock 1992; 38:115-21
9. Kleinschmidt S, Grundmann U, Knocke T, Silomon M, Bach F, Larsen R: Total intravenous anaesthesia with gamma-hydroxybutyrate (GHB) and sufentanil in patients undergoing coronary artery bypass graft surgery: A comparison in patients with unimpaired and impaired left ventricular function. Eur J Anaesth 1998; 15:559-64
10. Soltész S, Silomon M, Biedler A, Kleinschmidt S, Benak J, Molter GP: Gammahydroxybutyric acid-ethanolamide (LK 544). The suitability of LK 544 for sedation of patients in intensive care in comparison with midazolam. Anaesthesist 2001; 50:323-8
11. Crippen D, Safar P, Snyder C, Porter L: Dying pattern in volume-controlled herorrhagic shock in awake rats. Resuscitation 1991; 21:259-70
12. Bol CJJG, Vogelaar JPW, Tang J-P, Mandema JW: Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat. J Pharmacol Exp Ther 2000; 294:347-55
13. Van Sassenbroeck DK, De Paepe P, Belpaire FM, Rosseel M-T, Martens P, Boon PA, Buylaert WA: Relationship between gamma-hydroxybutyrate plasma concentrations and its electroencephalographic effects in the rat. J Pharm Pharmacol 2001; 53:1687-96
14. de Vriendt CA, Van Sassenbroeck DK, Rosseel MT, van de Velde EJ, Verstraete AG, Vander Heyden Y, Belpaire FM: Development and validation of a high-performance liquid chromatographic method for the determination of gamma-hydroxybutyric acid in rat plasma. J Chromatography B 2001; 752:85-90
15. Palatini P, Tedeschi L, Frison G, Padrini R, Zordan R, Orlando R, Gallimberti L, Gessa GL, Ferrara SD: Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol 1993; 45:353-6
16. Akaike H: A new look at the statistical model identification. IEEE Trans Automat Control AC 1974; 19:716-23
17. Gabrielsson J, Weiner D: Assessing the Goodness-of-Fit, Pharmacokinetic and Pharmacodynamic Data Analysis, 2nd Edition. Stockholm, Swedish Pharmaceutical Society, The Swedish Pharmaceutical Press, 1997, pp 289-309
18. Gregory TK, Pettus DC: An electroencephalographic processing algorithm specifically intended for analysis of cerebral electrical activity. J Clin Monit 1986; 2:190-7
19. Della Paschoa OE, Mandema JW, Voskuyl RA, Danhof M: Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats. J Pharmacol Exp Ther 1998; 284:460-6
20. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J: Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin Pharmacol Ther 1979; 25:358-71
21. Klockowski PM, Levy G: Kinetics of drug action in disease states: XXV. Effect of experimental hypovolemia on the pharmacodynamics and pharmacokinetics of desmethyldiazepam. J Pharmacol Exp Ther 1988; 245:508-12
22. Kleinschmidt S, Merzlufft F: Gamma-hydroxy-buttersaüre-hat sie einen stellenwert in anästhesie und intensivmedizin? Anästhesiol Intensivmed Notfallmed Schmerzther 1995; 30:393-402
23. Johansson B, Hardebo J-E: Cerebrovascular permeability and cerebral blood flow in hypertension induced by gammahydroxybutyric acid. Acta Neurol Scand 1982; 65:448-57
24. Wade CE, Kramer GC, Grady JJ, Fabian TC, Younes RN: Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: A meta-analysis of controlled clinical studies. Surgery 1997; 122:609-16
25. Berti F, Mandelli V, Spano PF, Vargiu L: Interaction of sodium gammahydroxybutyrate with catecholamines in rat heart and adipose tissue. Life Sci 1970; 9:683-9
26. Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA: Toward understanding the biology of a complex phenotype: Rat strain and substrain differences in the sensimotor gating-disruptive effects of dopamine agonists. J Neurosci 2000; 20:4325-36
27. Khanna JM, Kalant H, Shah G, Chau A: Tolerance to ethanol and crosstolerance to pentobarbital and barbital in four rat stains. Pharmacol Biochem Behav 1991; 39:705-9
28. Colombo G, Lobina C, Agabio R, Brunetti G, Diaz G, Littera M, Melis S, Pani M, Reali R, Serra S, Vacca G, Carai MAM, Gessa GL: Selective breeding of two rat lines differing in sensitivity to GHB and baclofen. Brain Res 2001; 902:130
29. Henthorn TK, Krejcie TC, Avram MJ: The relationship between alfentanil distribution kinetics and cardiac output. Clin Pharmacol Ther 1992; 52:190-6
30. Bjorkman S, Wada DR, Stanski DR: Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients. Anesthesiology 1998; 88:657-67
31. Krejcie TC, Henthorn TK, Shanks CA, Avram MJ: A recirculatory pharmacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs. J Pharmacol Exp Ther 1994; 269:609-16
32. Johnson KB, Kern SE, Hamber EA, McJames SW, Kohnstamm KM, Egan TD: Influence of hemorrhagic shock on remifentanil. A pharmacokinetic and pharmacodynamic analysis. Anesthesiology 2001; 94:322-32
33. Krejcie TC, Henthorn TK, Gentry WB, Niemann CU, Enders-Klein C, Shanks CA, Avram MJ: Modifications of blood volume alter the disposition of markers of blood volume, extracellular fluid, and total body water. J Pharmacol Exp Ther 1999; 291:1308-16
34. De Paepe P, Belpaire FM, Buylaert WA: The influence of hemorrhagic shock on the pharmacokinetics and the analgesic effect of morphine in the rat. Fundam Clin Pharmacol 1998; 12:624-30
35. Davies B, Morris T: Physiological parameters in laboratory animals and humans. Pharm Res 1993; 10:1093-5
36. Gibaldi M, Perrier D: Nonlinear Pharmacokinetics, Pharmacokinetics, 2nd Edition. Edited by Swarbrick J. New York, Marcel Dekker, 1982, pp 271-318
37. Macnab MSP, Macrae DJ, Guy E, Grant IS, Feely J: Profound reduction in morphine clearance and liver blood flow in shock. Intens Care Med 1986; 12:366-9
38. Pentel P, Benowitz NL: Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies. Clin Pharmacokinet 1984; 9:273-308
39. Dingemanse J, Danhof M, Breimer DD: Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: An overview. Pharmac Ther 1988; 38:1-52
40. Turnbull MJ, Watkins JW: Acute tolerance to barbiturate in the rat. Eur J Pharmacol 1976; 36:15-20
41. Bol CJJG, Danhof M, Stanski DR, Mandema JW: Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. J Pharmacol Exp Ther 1997; 283: 1051-8
42. Werner C, Hoffman WE, Kochs E, Schulte am Esch J, Albrecht RF: The effects of propofol on cerebral and spinal cord blood flows in rats. Anesth Analg 1993; 76:971-5